Email updates

Keep up to date with the latest news and content from BMC Ophthalmology and BioMed Central.

Open Access Highly Accessed Research article

A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension

David Eveleth*, Carla Starita and Charles Tressler

BMC Ophthalmology 2012, 12:9  doi:10.1186/1471-2415-12-9

Article Metrics

3324
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 53 accesses
  • Last 365 days: 594 accesses
  • All time: 3324 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information